Furthermore, based on the median expression levels of PBX2, PRMT1, SMARCC1, and IGF2BP2, the 85 HNSCC cases were categorized into high and low‐expression groups. The gene discussed is IGF2BP2; the disease is head and neck squamous cell carcinoma.